Pharmareferent - Indikation Gastroenterologie
€72.8k - €116.7k+ Annual target bonus + Sales commissions
Mid
Bachelor's
Neuss, Germany+3 moreMore locations: Hallbergmoos, Germany | Stuttgart, Germany | Munich, Germany
In PersonField-based sales role in Oberbayern/Schwaben; extensive regional travel and overnight stays, including possible weekend event work.
Sales & Account ManagementField Sales
About the job
Requirements
- A completed degree or doctorate is requested, preferably in natural sciences, pharmacy, health economics, or medicine; alternatively, recognized Pharmaberater qualification under § 75(3) is accepted.
- Initial professional experience in sales is advantageous.
- Ability to communicate precisely and make scientific arguments with opinion leaders on equal footing.
- Deep knowledge of health policy and the care landscape in gastroenterology is desirable.
- Willingness to learn, digital affinity, creativity, and proactivity.
- Strong cooperation and teamwork skills.
- Very good communication and rhetorical skills.
- Customer orientation and strong networking abilities.
- Very good written and spoken German and English.
- Willingness to travel and stay overnight frequently within the region; residence in the travel area is advantageous.
- Class B driver's license.
- Availability for weekend assignments at events and congresses.
Responsibilities
- Persuade customers of the value and benefits of products using scientific and communication skills to achieve sales and growth targets, and build sustainable business relationships by understanding customer needs.
- Identify market opportunities and further develop regional network structures.
- Develop and implement market-access and sales-promotion initiatives in a competitive environment, using resources effectively.
- Independently conduct regular market, account, and potential analyses to derive and implement effective regional sales strategies.
- Conduct informational events, potentially including presentations, and attend relevant national and regional events such as conferences and congresses.
- Identify and prioritize providers’ and patients’ needs and care gaps throughout the treatment pathway, and develop strategy and action plans as part of stakeholder management.
- Closely monitor the market and share relevant competitive and health-policy information with the appropriate cross-functional team contacts.
- Work closely across field-sales lines and within regional and cross-functional teams, contribute ideas proactively, and involve relevant functions to expand customer relationships and market access.
Desired Qualifications
- Deep knowledge of health policy and the care landscape in gastroenterology.
About the company
Johnson & Johnson develops prescription medicines and makes medical devices for hospitals, and unlike most big drugmakers, it runs both businesses under one roof. In 2015, its Darzalex became the first antibody drug approved for multiple myeloma, a blood cancer. Its medicines treat cancer, immune diseases such as psoriasis, and mental illnesses such as depression, and patented drugs bring in most of its sales. Its MedTech unit makes heart pumps, catheters that treat irregular heartbeats, surgical sutures, and Acuvue contact lenses. It was founded in 1886 to make sterile surgical dressings, is based in New Brunswick, New Jersey, and spun off its consumer brands, such as Tylenol and Band-Aid, as Kenvue in 2023.
Company Size
10,001+
Company Stage
IPO
Headquarters
New Brunswick, New Jersey
Founded
1886
Get referred to Johnson & Johnson
See people who can refer or advise you
Simplify's Take
What believers are saying
- Cancer drugs drive growth: oncology sales rose 17% to $7.4 billion in the June 2026 quarter, 29% of the total.
- Stock grants have gained value: J&J shares rose 58% in the year to September 2026, versus 23% for Pfizer.
- Students have a way in: J&J listed 1,897 open jobs in October 2026, including 201 internships, co-ops and early-career roles.
What critics are saying
- Its key immune drug trails: AbbVie's Skyrizi outsold Tremfya $5.5 billion to $2.0 billion in the June 2026 quarter.
- Orthopedics is leaving J&J: in September 2026, it was negotiating a $20 billion sale to buyout firm Apollo.
- Baby powder suits remain costly: in July 2026, J&J agreed to pay $5.5 billion to end about 76,000 cancer claims.
What makes Johnson & Johnson unique
- Its debt is rated safer than America's: S&P's top AAA rating goes to only two US companies, J&J and Microsoft.
- Employees rank above shareholders: J&J's 1943 Credo lists duties to patients, then staff and communities, with stockholders last.
- Its psoriasis pill is a first: Icotyde, approved March 2026, blocks an immune signal rivals target only by injection.
Help us improve and share your feedback! Did you find this helpful?
Benefits
- Health Insurance
- Dental Insurance
- Vision Insurance
- Life Insurance
- Disability Insurance
- 401(k) Retirement Plan
- 401(k) Company Match
- Paid Vacation
- Paid Sick Leave
- Paid Holidays
- Remote Work Options
- Performance Bonus